Market News Archives

From Waistlines to Warheads: How GLP‑1 Cash Is Quietly Fueling the Radiopharma Revolution -( $AZN $BMY $LLY )

by John F. Heerdink, Jr. April 20, 2026 554Views 0Likes

Eli Lilly is turning its GLP-1 windfall into a broader oncology and radiopharma push, just as a new generation of targeted alpha therapies steps onto center stage with companies like NAYA Therapeutics — and investors are starting to notice that “weight loss”…

Tim Cook Logs Out, Ternus Logs In As CEO: Wall Street Downloads Apple’s Next Chapter -( $AAPL $DIA $QQQ $SPY )

by John F. Heerdink, Jr. April 20, 2026 506Views 0Likes

Apple (AAPL) just handed Wall Street the kind of plot twist it secretly roots for: Tim Cook is stepping down as CEO, and longtime hardware whisperer John Ternus is sliding into the corner office, perfectly on cue with the market’s never‑ending search…

April 20, 2026 – Big Indexes Trim, Russell 2000 Hits ‘Add to Cart’ on Gain -( $EPRX $HIMS $NOK $NVDA $OPEN $SER $VISN $VIX $WMT Rise!)

by John F. Heerdink, Jr. April 20, 2026 6019Views 0Likes

US stocks pulled back from recent records on Monday as renewed strain around US-Iran peace efforts and the looming March retail sales and PMI data prompted investors to take profits and re‑price risk. Index moves and risk tone The S&P 500 (7,109.14,…

From Shopping Carts to Smart Carts: Walmart’s Digital Health Push Meets Lilly’s GLP‑1 Boom – ( $AMGN $LLY $MODD $NVO $PFE $WMT )

by John F. Heerdink, Jr. April 20, 2026 392Views 0Likes

Walmart’s (WMT) latest move into digital health reads less like a retail side-hustle and more like an opening bell in the next leg of the GLP‑1 trade, with syringes, smartphones, and stock tickers all lining up on aisle 7. As weight‑loss drugs…

From $5 Million EVs to $5 Silver: Why Luxury Cars, AI Chips, and Precious Metals Are All Having a Moment – ( $SPY $QQQ $DIA )

by John F. Heerdink, Jr. April 19, 2026 634Views 0Likes

Rolls-Royce just sold out a $5 million electric convertible that won’t arrive until 2028, AI chips are still powering indexes to record highs despite a shooting war with Iran, and over the past 50 years gold has quietly beaten silver while both…

The Starlink Effect: How a Private Satellite Giant Is Quietly Moving Public Stocks

by John F. Heerdink, Jr. April 18, 2026 434Views 0Likes

On most days, Starlink doesn’t trade, but it certainly behaves as if it does. The satellite internet business inside SpaceX remains privately held, yet its growth is rippling across public markets in ways that are getting harder for investors to ignore. With…

April 17, 2026 – From Strait of Hormuz to Straight Up: How De‑Escalation Sent the S&P to Yet Another Therapy‑Defying High -( $AVGO $EPRX $HIMS $MCD $MODD $NVDA $OPEN $SER $TSLA Rise!)

by John F. Heerdink, Jr. April 17, 2026 5953Views 0Likes

U.S. equities extended their powerful rebound this week, with the major indices logging a third straight week of gains and fresh record highs as easing Middle East tensions, softer oil, and broadly constructive macro data fueled risk appetite. Index performance and drivers…

From Shots to Patch Pumps: How Eli Lilly and Modular Medical Are Quietly Repricing Metabolic Risk -( $LLY $MODD )

by John F. Heerdink, Jr. April 17, 2026 642Views 0Likes

Eli Lilly’s (LLY) CEO is positioning the weight‑loss boom as a long runway that extends well beyond today’s GLP‑1 headlines, and a tiny pump maker may have just found itself a VIP seat on the same flight. The Second Act of the…

Tribe Public Shines a Spotlight on Naya Therapeutics as Next-Gen Oncology Steps Onto the Investor Stage

by John F. Heerdink, Jr. April 17, 2026 550Views 0Likes

Tribe Public’s latest CEO event video, titled “Can Targeted Alpha Therapy Cure Cancer” brings Naya Therapeutics to center stage in a format that feels more like a well-curated Wall Street salon than a standard biotech webinar. The Tribe model—investor-driven CEO access in…

Speculation Hangover? Jim Cramer’s Playbook for Sober Investors in a Drunk Market -( $CEG $GE $HON $IBM $DIA $QQQ $SPY )

by John F. Heerdink, Jr. April 17, 2026 542Views 0Likes

Jim Cramer is once again playing Wall Street’s unofficial hall monitor, warning that the latest wave of speculation looks less like disciplined investing and more like a freshman-year options lab gone rogue—yet his message is ultimately bullish for investors willing to trade…

Market News

Your Guide To Staying Informed In The Markets